Cargando…

Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir”

Detalles Bibliográficos
Autores principales:	Chen, Ting, Fei, Cheng-Yin, Chen, Yi-Ping, Sargsyan, Karen, Liang, Jian-Jong, Liao, Chun-Che, Lin, Yi-Ling, Chang, Chun-Ping, Yuan, Hanna S., Lim, Carmay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204750/ https://www.ncbi.nlm.nih.gov/pubmed/34136759 http://dx.doi.org/10.1021/acsptsci.1c00106

Ejemplares similares

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir
por: Chen, Ting, et al.
Publicado: (2021)

Correction: Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors
por: Sargsyan, Karen, et al.
Publicado: (2021)

Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors
por: Sargsyan, Karen, et al.
Publicado: (2020)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
por: Saha, Tushar, et al.
Publicado: (2023)

The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis
por: Dong, Chuanjiang, et al.
Publicado: (2022)

Arrangement of 3D structural motifs in ribosomal RNA
por: Sargsyan, Karen, et al.
Publicado: (2010)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
por: Sargsyan, Karen, et al.
Publicado: (2023)

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
por: Hsu, Hsing-Yu, et al.
Publicado: (2021)

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection
por: Chen, Hao, et al.
Publicado: (2022)

GeoPCA: a new tool for multivariate analysis of dihedral angles based on principal component geodesics
por: Sargsyan, Karen, et al.
Publicado: (2012)

GeoPCA: a new tool for multivariate analysis of dihedral angles based on principal component geodesics
por: Sargsyan, Karen, et al.
Publicado: (2015)

Identifying RNA-binding residues based on evolutionary conserved structural and energetic features
por: Chen, Yao Chi, et al.
Publicado: (2014)

Antibacterial Activity of Ebselen
por: Maślanka, Marta, et al.
Publicado: (2023)

Efficient Strategy to Design Protease Inhibitors: Application to Enterovirus 71 2A Protease
por: Chen, Ting, et al.
Publicado: (2022)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

Synergistic antibacterial effect of silver and ebselen against multidrug‐resistant Gram‐negative bacterial infections
por: Zou, Lili, et al.
Publicado: (2017)

Effects of ebselen and N-acetyl cysteine on replicative aging of primary human fibroblast strains
por: Marthandan, Shiva
Publicado: (2015)

Sequence-motif Detection of NAD(P)-binding Proteins: Discovery of a Unique Antibacterial Drug Target
por: Hua, Yun Hao, et al.
Publicado: (2014)

Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission
por: Simanjuntak, Yogy, et al.
Publicado: (2018)

Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases
por: Ou, An-te, et al.
Publicado: (2021)

Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines
por: Wildner, Guilherme, et al.
Publicado: (2023)

The Potential Use of Ebselen in Treatment-Resistant Depression
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Chemistry Related to the Catalytic Cycle of the Antioxidant Ebselen
por: Sands, Kai N., et al.
Publicado: (2023)

Ebselen Inhibits Hepatitis C Virus NS3 Helicase Binding to Nucleic Acid and Prevents Viral Replication
por: Mukherjee, Sourav, et al.
Publicado: (2014)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021)

Disulfiram Induced Psychosis
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Disulfiram Treatment of Alcoholism
por: Anton, Raymond F.
Publicado: (1995)

Encephalopathy caused by disulfiram
por: Sant’Angelo, R., et al.
Publicado: (2021)

Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line
por: Lafi, Zainab, et al.
Publicado: (2023)

Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
por: Favrot, Lorenza, et al.
Publicado: (2013)

Evaluation of ebselen supplementation on cryopreservation medium in human semen
por: Khodayari Naeini, Zohreh, et al.
Publicado: (2014)

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
por: Küppers, Jim, et al.
Publicado: (2016)

Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)

New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential
por: Pacuła, Agata J., et al.
Publicado: (2017)

Micelle-embedded coating with ebselen for nitric oxide generation
por: Yang, Li, et al.
Publicado: (2019)

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
por: Santi, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sup46vg4irvjn8fd9pjbkh4oaf